METTL3 depletion in normal human hematopoietic stem/progenitor cells (HSPCs) and leukemia cells leads to a decline in RNA m6A levels, to promotion of differentiation, and to reduction of proliferation in HSPCs and myeloid leukemia cells. This evidence concerns the gene METTL3 and myeloid leukemia.